Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Employment agrmnt Quarterly results Consulting agrmnt Director departure
|
Ampio Pharmaceuticals, Inc. (AMPE)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/09/2023 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Bought 25,000 shares
@ $0.296, valued at
$7.4k
|
|
05/26/2023 |
4
| MARTINO MICHAEL A (CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Bought 76,890 shares
@ $0.2877, valued at
$22.1k
|
|
05/17/2023 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Bought 32,534 shares
@ $0.2743, valued at
$8.9k
|
|
05/12/2023 |
4
| Stevens David R (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Bought 25,000 shares
@ $0.22, valued at
$5.5k
Bought 25,000 shares
@ $0.215, valued at
$5.4k
Bought 45,000 shares
@ $0.22, valued at
$9.9k
|
|
03/02/2022 |
4
| JOBES ELIZABETH VARKI (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 150,000 options to buy
@ $0.4513, valued at
$67.7k
|
|
02/10/2022 |
4
| Bar-Or David (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 75,000 options to buy
@ $0.5295, valued at
$39.7k
|
|
01/04/2022 |
4
| STOKELY DAN (CFO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Paid exercise price by delivering 22,914 shares
@ $0.57, valued at
$13.1k
|
|
01/04/2022 |
4
| Cherevka Holli (PRESIDENT AND COO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Paid exercise price by delivering 47,200 shares
@ $0.57, valued at
$26.9k
|
|
01/04/2022 |
4
| MACALUSO MICHAEL (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Paid exercise price by delivering 68,400 shares
@ $0.57, valued at
$39k
|
|
01/03/2022 |
4
| MARTINO MICHAEL A (INTERIM CHAIRMAN AND CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 250,000 options to buy
@ $0.57, valued at
$142.5k
|
|
01/03/2022 |
4
| Giles Richard B (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 75,000 options to buy
@ $0.56, valued at
$42k
|
|
01/03/2022 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 75,000 options to buy
@ $0.56, valued at
$42k
|
|
01/03/2022 |
4
| Stevens David R (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 75,000 options to buy
@ $0.56, valued at
$42k
|
|
01/03/2022 |
4
| COELHO PHILIP H (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 75,000 options to buy
@ $0.56, valued at
$42k
|
|
11/24/2021 |
4
| MARTINO MICHAEL A (INTERIM CHAIRMAN AND CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 750,000 options to buy
@ $1.14, valued at
$855k
|
|
10/28/2021 |
4
| STOKELY DAN (CFO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Paid exercise price by delivering 28,127 shares
@ $1.64, valued at
$46.1k
|
|
10/28/2021 |
4
| Cherevka Holli (PRESIDENT AND COO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Paid exercise price by delivering 41,980 shares
@ $1.64, valued at
$68.8k
|
|
10/28/2021 |
4
| MACALUSO MICHAEL (CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Paid exercise price by delivering 43,470 shares
@ $1.64, valued at
$71.3k
|
|
10/25/2021 |
4
| MARTINO MICHAEL A (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 150,000 options to buy
@ $1.67, valued at
$250.5k
|
|
10/25/2021 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 150,000 options to buy
@ $1.67, valued at
$250.5k
|
|
10/15/2021 |
4
| Bar-Or David (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 120,000 options to buy
@ $1.67, valued at
$200.4k
|
|
10/15/2021 |
4
| COELHO PHILIP H (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 120,000 options to buy
@ $1.67, valued at
$200.4k
|
|
10/15/2021 |
4
| Giles Richard B (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 120,000 options to buy
@ $1.67, valued at
$200.4k
|
|
10/15/2021 |
4
| Stevens David R (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 120,000 options to buy
@ $1.67, valued at
$200.4k
|
|
10/13/2021 |
4
| MACALUSO MICHAEL (CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 950,000 shares
@ $0 |
|
10/13/2021 |
4
| STOKELY DAN (CFO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 335,000 shares
@ $0 |
|
10/13/2021 |
4
| Cherevka Holli (COO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 500,000 shares
@ $0 |
|
06/29/2021 |
4
| STOKELY DAN (CFO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Sold 22,500 shares
@ $1.79, valued at
$40.3k
Exercised 22,500 options to buy
@ $0.43, valued at
$9.7k
|
|
05/25/2021 |
4
| Cherevka Holli (COO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Sold 2,603 shares
@ $2, valued at
$5.2k
Exercised 2,603 options to buy
@ $0.51, valued at
$1.3k
|
|
05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2021 |
4
| STOKELY DAN (CFO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Sold 35,000 shares
@ $1.828, valued at
$64k
Exercised 35,000 options to buy
@ $0.43, valued at
$15.1k
|
|
04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/29/2021 |
4
| Cherevka Holli (COO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Sold 74,631 shares
@ $2, valued at
$149.3k
Exercised 30,000 options to buy
@ $0.51, valued at
$15.3k
Exercised 44,631 options to buy
@ $0.51, valued at
$22.8k
|
|
|
|
|